Blair William & Co. IL lessened its holdings in Danaher Co. (NYSE:DHR) by 6.4% during the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,608,796 shares of the conglomerate’s stock after selling 110,589 shares during the period. Danaher accounts for approximately 1.1% of Blair William & Co. IL’s portfolio, making the stock its 12th largest holding. Blair William & Co. IL owned approximately 0.23% of Danaher worth $157,517,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. A.R.T. Advisors LLC increased its stake in Danaher by 10.8% in the first quarter. A.R.T. Advisors LLC now owns 38,900 shares of the conglomerate’s stock valued at $3,808,000 after acquiring an additional 3,800 shares during the last quarter. CAMG Solamere Management LLC increased its stake in Danaher by 828.7% in the first quarter. CAMG Solamere Management LLC now owns 100,586 shares of the conglomerate’s stock valued at $940,000 after acquiring an additional 89,755 shares during the last quarter. HM Payson & Co. increased its stake in Danaher by 3.0% in the first quarter. HM Payson & Co. now owns 219,767 shares of the conglomerate’s stock valued at $21,517,000 after acquiring an additional 6,453 shares during the last quarter. Rampart Investment Management Company LLC increased its stake in Danaher by 231.6% in the first quarter. Rampart Investment Management Company LLC now owns 24,824 shares of the conglomerate’s stock valued at $2,431,000 after acquiring an additional 17,339 shares during the last quarter. Finally, Epoch Investment Partners Inc. increased its stake in Danaher by 2.1% in the first quarter. Epoch Investment Partners Inc. now owns 3,818,204 shares of the conglomerate’s stock valued at $373,840,000 after acquiring an additional 77,733 shares during the last quarter. 76.61% of the stock is currently owned by institutional investors and hedge funds.

Shares of Danaher opened at $103.00 on Monday, Marketbeat Ratings reports. Danaher Co. has a 12-month low of $78.97 and a 12-month high of $104.82. The stock has a market cap of $71.95 billion, a PE ratio of 25.56, a P/E/G ratio of 1.93 and a beta of 1.03. The company has a current ratio of 1.59, a quick ratio of 1.15 and a debt-to-equity ratio of 0.38.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Thursday, April 19th. The conglomerate reported $0.99 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.94 by $0.05. Danaher had a return on equity of 11.39% and a net margin of 13.56%. The firm had revenue of $4.70 billion for the quarter, compared to analysts’ expectations of $4.54 billion. During the same period last year, the firm earned $0.85 earnings per share. The company’s revenue for the quarter was up 11.6% compared to the same quarter last year. analysts anticipate that Danaher Co. will post 4.45 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, July 27th. Stockholders of record on Friday, June 29th will be issued a dividend of $0.16 per share. The ex-dividend date is Thursday, June 28th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.62%. Danaher’s dividend payout ratio is currently 15.88%.

DHR has been the topic of a number of research analyst reports. Robert W. Baird reissued a “buy” rating and issued a $106.00 target price on shares of Danaher in a research note on Friday, April 20th. Zacks Investment Research raised Danaher from a “hold” rating to a “buy” rating and set a $113.00 target price on the stock in a research note on Thursday, May 17th. Credit Suisse Group reissued an “outperform” rating on shares of Danaher in a research note on Friday, March 9th. Stifel Nicolaus reissued a “buy” rating and issued a $114.00 target price (up previously from $108.00) on shares of Danaher in a research note on Thursday, April 19th. Finally, Morgan Stanley increased their target price on Danaher from $112.00 to $113.00 and gave the company an “overweight” rating in a research note on Friday, April 20th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fourteen have issued a buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of $105.69.

In other news, Director Linda P. Hefner sold 18,001 shares of the stock in a transaction dated Thursday, April 26th. The shares were sold at an average price of $101.51, for a total transaction of $1,827,281.51. Following the completion of the sale, the director now directly owns 25,225 shares in the company, valued at $2,560,589.75. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Thomas Patrick Joyce, Jr. sold 120,354 shares of the stock in a transaction dated Friday, April 20th. The stock was sold at an average price of $101.17, for a total transaction of $12,176,214.18. Following the sale, the insider now owns 151,959 shares of the company’s stock, valued at $15,373,692.03. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 241,940 shares of company stock valued at $24,527,925. 11.90% of the stock is currently owned by company insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.